Major companies in the mattresses, blinds and shades market include Tempur Sealy International Inc; Serta Simmons Bedding LLC; Hunter Douglas N V; Springs Window Fashions LLC and Select Comfort Corp.
The global mattresses, blinds and shades market is expected to grow from $117.49 billion in 2020 to $126.66 billion in 2021 at a compound annual growth rate (CAGR) of 7.8%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $165.75 billion in 2025 at a CAGR of 7%.
The mattresses, blinds and shades market consists of sales of mattresses, blinds and shades by entities (organizations, sole traders and partnerships) that are involved in producing mattresses, blinds and shades. Products of the industry include mattresses, venetian blinds, window blinds, shades, curtain, drapery rods, and drapery fixtures. The mattresses, blinds and shades market is segmented into mattresses and blind and shade.
Asia Pacific was the largest region in the global mattresses, blinds and shades market, accounting for 44% of the market in 2020. Western Europe was the second largest region accounting for 25% of the global mattresses, blinds and shades market. Africa was the smallest region in the global mattresses, blinds and shades market.
The demand for organic and eco-friendly mattresses is increasing in many developed and developing economies. This is mainly due to growing consumer preference for healthier products and increasing concerns about harmful chemicals, pesticides and allergies. Organic and eco-friendly mattresses are manufactured using organic and natural materials, which reduce both health and environmental risks. To cater to the growing consumer demand for organic and eco-friendly products, several mattresses manufacturers have switched over to alternative materials such as organic cotton, wool, natural latex, organic latex, plant-based foams, and other plant materials. Some of the companies that use plant-based foams and latex to produce mattresses include Sealy and Simmons.
The outbreak of Coronavirus disease (COVID-19) has acted as a massive restraint on the mattresses, blinds and shades manufacturing market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID 19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China and spread globally including Western Europe, North America and Asia. Steps by national governments to contain the transmission have resulted in halting of manufacturing activities and a decline in economic activity with countries entering a state of ’lock down’ and the outbreak is expected to continue to have a negative impact on businesses throughout 2020 and into 2021. However, it is expected that the mattresses, blinds and shades manufacturing market will recover from the shock across the forecast period as it is a ’black swan’ event and not related to ongoing or fundamental weaknesses in the market or the global economy.
Increasing demand for online shopping is expected to help the mattresses, blinds and shades manufacturing market grow. Manufacturers can now sell their products on a larger platform than before, which will increase their customer base geographically driving the growth of the mattresses, blinds and shades manufacturing market. In countries such as India, for instance, e-commerce portals have boosted the sales of blinds and shades manufacturers by giving larger exposure to producers who were confined to one geography.
Our reports have been used by over 10K customers, including:
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
The Asia Pacific organoids market is expected to reach US$ 513.74 million in 2027 from US$ 97.02 million in 2019. The market is estimated to grow at a CAGR of 23.1% from 2020 to 2027. Rising adoption of biobanking and tumor modelling and alternatives for animal testing models acting as kingpins are expected to augment the growth of the...
The Europe organoids market is projected to reach US$ 1,260.08 million by 2027 from US$ 247.85 million in 2019; it is estimated to grow at a CAGR of 22.5% from 2020 to 2027. Increasing demand for tumor modelling and biobanking and rising adoption of personalized drugs are expected to drive the market. Personalized medicine is a growing...
The Middle East & Africa organoids market is expected to reach US$ 141.26 million in 2027 from US$ 37.34 million in 2019; the market is estimated to grow at a CAGR of 20.9% from 2020 to 2027. The growth of the market can be attributed to growing research on organoids in the Middle East & Africa region and rising focus on developing alternatives...
The North America organoids market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019. The market is anticipated to grow at a CAGR of 21.7% from 2020 to 2027. Growth of the North America organoids market is attributed to emergence of three-dimensional (3D) organoids and rise in investments in research. However,...
The South and Central America nurse call systems market is expected to reach US$ 200.11 million by 2027 from US$ 87.23 million in 2019. The market is estimated to grow at a CAGR of 10.8% from 2020-2027. The growth of the South and Central America nurse call systems market is driven by the growing incidence of Alzheimer’s disease and dementia...
Digital Pathology Market Size, Share & Trends Analysis Report By Product (Software, Device), By Application (Drug Discovery & Development, Academic Research), By End-use, By Region, And Segment Forecasts, 2021 - 2028 Digital Pathology Market Growth & Trends The global digital pathology market...
An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional...
KEY FINDINGS The global disposable patient positioning products market is anticipated to register a CAGR of 3.21%, during the forecast years of 2021 to 2028. The primary market growth drivers include the growing volume of surgeries, the rise in the geriatric population, and the surging investments across the healthcare...
The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies,...
Therapy
Pathology
Probiotics
Autoimmune Disease
Infectious Disease
APAC
World
Europe
Central America
Health Expenditure
Diabetes Prevalence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.